These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism. Fornal C; Radulovacki M J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135 [TBL] [Abstract][Full Text] [Related]
23. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors. Harrison AA; Markou A J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559 [TBL] [Abstract][Full Text] [Related]
24. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415 [TBL] [Abstract][Full Text] [Related]
25. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability. Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811 [TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output. van Amsterdam C; Seyfried CA Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272 [TBL] [Abstract][Full Text] [Related]
27. The GABAergic Gudden's dorsal tegmental nucleus: A new relay for serotonergic regulation of sleep-wake behavior in the mouse. Chazalon M; Dumas S; Bernard JF; Sahly I; Tronche F; de Kerchove d'Exaerde A; Hamon M; Adrien J; Fabre V; Bonnavion P Neuropharmacology; 2018 Aug; 138():315-330. PubMed ID: 29908240 [TBL] [Abstract][Full Text] [Related]
28. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice. Darmani NA; Reeves SL Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031 [TBL] [Abstract][Full Text] [Related]
29. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910 [TBL] [Abstract][Full Text] [Related]
30. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine. Currie PJ; Coscina DV; Fletcher PJ Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586 [TBL] [Abstract][Full Text] [Related]
31. Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness. Monti JM; Jantos H Neuropharmacology; 1994 May; 33(5):705-8. PubMed ID: 7936106 [TBL] [Abstract][Full Text] [Related]
32. Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats. Body S; Kheramin S; Mobini S; Ho MY; Velazquez-Martinez DN; Bradshaw CM; Szabadi E Behav Pharmacol; 2002 Dec; 13(8):603-14. PubMed ID: 12478210 [TBL] [Abstract][Full Text] [Related]
33. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Carli M; Samanin R Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407 [TBL] [Abstract][Full Text] [Related]
34. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle. Monti JM; Jantos H Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355 [TBL] [Abstract][Full Text] [Related]
36. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A; Millan MJ Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475 [TBL] [Abstract][Full Text] [Related]
37. Sleep effects following intrathecal administration of the 5-HT1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in rats. Bjørkum AA; Bjorvatn B; Neckelmann D; Ursin R Brain Res; 1995 Sep; 692(1-2):251-8. PubMed ID: 8548311 [TBL] [Abstract][Full Text] [Related]
38. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex. Invernizzi R; Bramante M; Samanin R Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551 [TBL] [Abstract][Full Text] [Related]
39. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors. D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats. Yoshitake T; Kehr J Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]